by 
Market Overview
The ENFit Syringes Market revolves around specialized enteral feeding devices designed to comply with ISO 80369‑3 standards to prevent tubing misconnections. In 2025, the ENFit Syringes Market was valued at approximately USD 850 million and is on track to reach about USD 1.38 billion by 2033, highlighting its growing relevance and adoption in healthcare settings.
2. AI and Innovation
Although the ENFit Syringes Market primarily focuses on safety and standardization, innovation may emerge through manufacturing enhancements, smart packaging, or integration with digital healthcare tools to streamline administration workflows and enhance patient safety.
3. Future Trends of the Market
Looking ahead, the ENFit Syringes Market is likely to evolve toward user-centric design, incorporation of smart alerts to reduce misconnect risks, and expanded acceptance across home healthcare and remote care environments.
4. Rising Demands of the Market
Rising awareness of patient safety and enteral misconnection prevention is fueling the ENFit Syringes Market. Surging chronic disease rates and growing demand for enteral nutrition, particularly in home healthcare, amplify the need for reliable ENFit-compliant devices.
5. Key Market Highlights
Key highlights include MID to large-volume syringes—particularly 60 mL and above—dominating the ENFit Syringes Market. Disposable ENFit syringes lead by preference, and hospitals remain the primary segment, supported by strong safety standards and direct procurement dynamics.
6. Market Growth Drivers
Growth in the ENFit Syringes Market is driven by stricter patient safety regulations, alignment with ISO standards, increasing chronic illness prevalence, and greater adoption of secure enteral feeding solutions across healthcare settings.
Also Read@ https://www.dailytechbulletin.com/advanced-technical-ceramics-market/
7. Restraints
The ENFit Syringes Market faces constraints such as high conversion costs for healthcare facilities, logistical challenges managing legacy and new systems, resistance from clinical staff accustomed to older devices, and fragmented regulation across regions.
8. Opportunities
Opportunities in the ENFit Syringes Market include increased adoption in home care, broader awareness of misconnection risks, strategic partnerships with healthcare providers, and the development of modular or smart-enabled ENFit devices.
9. Regional Insights
North America currently leads in the ENFit Syringes Market thanks to early regulatory adoption and patient safety mandates. Meanwhile, Asia‑Pacific is the fastest-growing region due to expanding healthcare infrastructure. Europe sees steady uptake, and emerging regions show gradual market expansion.
Enfit Syringes Market Companies
- BD (Becton, Dickinson and Company)
- Cardinal Health
- Baxter International
- Medtronic
- Terumo Corporation
- Vygon SA
- B. Braun Melsungen AG
- Moog Inc.
- Smiths Medical (ICU Medical)
- Avanos Medical
- Medela AG
- GBUK Group Ltd
- Amsino International, Inc.
- Kentec Medical, Inc.
- NeoMed Inc.
- Applied Medical Technology, Inc.
- Vesco Medical, LLC
- Dynarex Corporation
- HMC Group
- Cair LGL
Recent Developments
- In September 2024, Azurity Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative dose forms and formulations of products that align with patient needs and unmet needs, announced the U.S. Food and Drug Administration (FDA) has approved Nymalize(r) (nimodipine) oral solution in a 30 mg / 5 L prefilled ENFit(r) syringe.
- In 2023, Fortune Medical manufactured two ENFit-compatible silicone feeding tubes (gastrostomy and nasogastric), which would help enteral feeding systems that conform to ENFit connectors or increase compatibility with ENFit-compatible syringes.
Visit For more@ https://www.precedenceresearch.com/
